Drug Profile
MN 201
Alternative Names: MN-201Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Marillion Pharmaceuticals
- Class Antineoplastics; Chemopreventatives; Small molecules; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Solid-tumours in USA (PO)
- 26 Oct 2007 Phase-I clinical trials in Solid tumours in USA (PO)